Youngsters under the age of 16 will reportedly have to undergo 13½ hours of medical assessments before being able to access trans healthcare under a new trial for puberty blockers. Details of the NHS-commissioned study of the effectiveness of puberty-blocking medication were announced over the weekend. Researchers from King's College London said the two-year Pathways trial would analyse the physical, social and emotional wellbeing of about 220 young teenagers. However, campaigners have described the trial as "intrusive and distressing"...